Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
Article in Blood Cancer Journal (June 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
The numerous facets of 1q21+ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review)
Article in Oncology Letters (April 2024)
Efficacy Analysis of Bortezomib Combined with Lenalidomide in Newly Diagnosed Multiple Myeloma with 1q21 Gain/Amp
Article in Technology in Cancer Research & Treatment (January 2024)